A unique triadin exon deletion causing a null phenotype

Barry O’Callaghan, Jules C. Hancox, Graham Stuart, Catherine Armstrong, Maggie Williams, Alison Hills, Hazel Pearce, Carolyn L. Dent, Mary Gable, Mark Walsh

HeartRhythm Case Reports · 2018 · 13 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

Triadin is a transmembrane protein located in the sarcoplasmic reticulum; it interacts with both ryanodine (RYR2) and calsequestrin (CASQ2) to facilitate calcium homeostasis in the human cardiac and skeletal muscle cells.1 Pathogenic variants in the RYR2 and CASQ2 genes are more commonly associated with catecholaminergic polymorphic ventricular tachycardia (CPVT). Triadin is a more recently acknowledged protein, wherein genetic aberrations in triadin are responsible for a number of malignant arrhythmic syndromes, particularly in younger children.

References

12